This is a three-year research study for people with primary membranous nephropathy (primary MN). The study will test if combining belimumab and rituximab is effective in treating Primary MN.

About 1 out of 5 women who are overweight or report snoring will test positive for sleep apnea during pregnancy. The most commonly prescribed treatment for sleep apnea is a small device called a CPAP. The CPAP just helps you to breathe in a normal pattern during sleep. Sleep apnea is common in pregnancy; it can affect the quality of your sleep and how you feel and function during the day. The goal of this study is to understand if using CPAP in pregnancy can help women have healthier pregnancies.

Are you pregnant? Would you like to have some extra ultrasounds of your baby? We're currently recruiting pregnant women who would like to participate in this ultrasound study. You will be able to have an extra ultrasound up to every two weeks (unless asked to return sooner) - you decide how often you would like to come.

Do you have Peripheral T Cell Lymphoma? Has your cancer come back or did it not get better with the last treatment you were given? If so, you may be eligible to participate in this gene therapy research study to learn more about using your own modified immune cells as possible treatment.

To evaluate the safety and efficacy of a device removing lipids from the blood using an apheresis device in treating primary FSGS

We want to see how different approaches to group mentoring will impact postdoctoral fellows and assistant professors in both their personal and professional lives. This study will include 9 months of group meetings.

Have you been diagnosed with pancreatic cancer? If so, you may be able to take part in a research study looking at the efficacy of neoadjuvant FOLFIRINOX in subjects with non-metastatic pancreatic cancer.

If you have been treated with ANCA vasculitis and you are now in remission, you may be able to participate in a study to test if a specific blood test can help your doctor decide if you need maintenance therapy.

This study consists of two online surveys and one laboratory visit on the UNC campus. Plus, a subset of participants will be randomized to make small shifts in their daily behaviors for 35 consecutive days and all participants will complete brief nightly surveys during that 35-day phase. Some participants will also watch a short, 10 minute video.

Have you been diagnosed with multiple myeloma or high-risk smoldering multiple myeloma? If so, you may be able to take part in a research study looking at how drugs used to treat multiple myeloma work.